← Eichor
Study identifier: NCT07593885 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Condition: Dry Eye  ·  Sponsor: Dr. Gerhard Mann chem.-pharm. Fabrik GmbH

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

This description comes directly from the study's public registry record.

Talk to the study team

Natasa Orlic-Pleyer  ·  03033093318  ·  natasa.orlic-pleyer@bausch.com

Always discuss trial participation with your own doctor first.

Locations (5)

Universitäts-Augenklinik HeidelbergHeidelberg, Baden-Wurttemberg, GermanyNot Yet Recruiting
Chiemsee Augentagesklinik, PrienBad Endorf, Bavaria, GermanyNot Yet Recruiting
Augen & Haut Zentrum-Praxis Dr. JacobiNuremberg, Bavaria, GermanyRecruiting
Augen-Zentrum-NordwestAhaus, North Rhine-Westphalia, GermanyNot Yet Recruiting
University Saarland Medical CenterHomburg, Saarland, GermanyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07593885